Goodwin Procter advised WIND Ventures on the deal. WIND Ventures (Copec Overseas SpA) announced its investment in Yummy. In addition to WIND Ventures, the round was led...
WIND Ventures’ Investment in Yummy
Ivella’s $3.5 Million Seed Round Financing
Goodwin Procter advised Ivella on the deal. Ivella announced the completion of its $3.5 million seed round, which was led by Anthemis, Financial Venture Studio and Soma...
Shellworks’ $6.2 Million Seed Financing Round
Goodwin Procter advised Shellworks on the deal. Shellworks announced its $6.2 million seed financing round led by London-based VC LocalGlobe, backer of firms like TweetDeck and TransferWise....
Moka.care’s €15 Million Series A Financing
Goodwin Procter advised Left Lane Capital on the deal. Left Lane Capital announced the €15 million Series A financing of Moka.care, a French startup that focuses on...
Sichuan Kelun-Biotech Biopharmaceutical’s License Agreement with Merck
Goodwin Procter advised Sichuan Kelun-Biotech Biopharmaceutical Co. on the deal. Sichuan Kelun-Biotech Biopharmaceutical Co. announced its exclusive license and collaboration agreement with Merck for ex-China development...
Advent International’s Fundraising
Goodwin advised Advent International on the deal. Advent International announced its fundraising for its flagship fund, Advent International GPE X. The fund reached its hard cap of...
Tranch’s US$4.25 Million Pre-seed Equity and Debt Funding
Goodwin advised Tranch on the deal. Tranch announced its US$4.25 million pre-seed equity and debt funding. The funding round is led by Flash Ventures the pre-seed investor...
BridgeBio’s $110 Million Sale of Priority Review Voucher
Goodwin Procter advised BridgeBio on the deal. BridgeBio announced its definitive agreement with an undisclosed purchaser to sell its rare pediatric disease Priority Review Voucher for $110...
BridgeBio Pharma’s License Agreement with Bristol Myers Squibb
Goodwin Procter advised BridgeBio Pharma, Inc. on the deal. BridgeBio Pharma, Inc. (Nasdaq: BBIO) announced its exclusive license agreement wit Bristol Myers Squibb to develop and...
Thermo Fisher Scientific’s Investment in Ionpath
Goodwin Procter advised Ionpath, Inc. on the deal. Thermo Fisher Scientific announced its strategic investment in Ionpath, Inc. Ionpath, Inc., based in Menlo Park, California, is a...
Future Plc’s Acquisition of WhoWhatWear
Holland & Knight advised Future plc on the deal while Goodwin Procter represented Clique Brands. Future plc (LSE: FUTR), the global platform for specialist media, announced its...
Shutterstock’s $210 Million Acquisition of Pond5
Goodwin Procter advised Pond5 on the deal, while Cahill advised Shutterstock in the acquisition and in a $100 million revolving credit facility. Pond5 announced its acquisition by...